These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 24627175

  • 1. Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma.
    Thomson NC.
    Evid Based Med; 2014 Aug; 19(4):135. PubMed ID: 24627175
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of omalizumab in severe asthma with fungal sensitisation: a case report.
    Di Stefano F, Cinti B, Antonicelli L.
    Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):56-9. PubMed ID: 24702879
    [Abstract] [Full Text] [Related]

  • 3. Omalizumab in asthma: an update on recent developments.
    Humbert M, Busse W, Hanania NA, Lowe PJ, Canvin J, Erpenbeck VJ, Holgate S.
    J Allergy Clin Immunol Pract; 2014 Jan; 2(5):525-36.e1. PubMed ID: 25213045
    [Abstract] [Full Text] [Related]

  • 4. Severe persistent asthma responsive to off-label use of omalizumab despite high and low levels of total serum IgE.
    Asai N, Ohkuni Y, Komatsu A, Matsunuma R, Nakashima K, Kaneko N.
    J Bras Pneumol; 2011 Jan; 37(4):567-70. PubMed ID: 21881749
    [No Abstract] [Full Text] [Related]

  • 5. How do we interpret the data supporting the use of omalizumab for severe asthma?
    Lavietes MH.
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):335-6. PubMed ID: 25256024
    [No Abstract] [Full Text] [Related]

  • 6. Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study.
    Tajiri T, Niimi A, Matsumoto H, Ito I, Oguma T, Otsuka K, Takeda T, Nakaji H, Inoue H, Iwata T, Nagasaki T, Kanemitsu Y, Izuhara Y, Mishima M.
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):470-5.e2. PubMed ID: 24994694
    [Abstract] [Full Text] [Related]

  • 7. Monitoring Allergic Patients on Omalizumab with Free and Total Serum IgE Measurements.
    Hamilton RG.
    J Allergy Clin Immunol Pract; 2016 Oct; 4(2):366-8. PubMed ID: 26968963
    [No Abstract] [Full Text] [Related]

  • 8. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P, Sauty A, Rochat T.
    Rev Med Suisse; 2007 Jan 10; 3(93):56-9. PubMed ID: 17354662
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
    Holgate ST, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF, Bousquet J, Kerstjens HA, Fox H, Thirlwell J, Cioppa GD, Omalizumab 011 International Study Group.
    Clin Exp Allergy; 2004 Apr 10; 34(4):632-8. PubMed ID: 15080818
    [Abstract] [Full Text] [Related]

  • 10. Omalizumab in the treatment of asthma.
    Tan R, Corren J.
    Expert Rev Respir Med; 2011 Dec 10; 5(6):747-56. PubMed ID: 22082161
    [Abstract] [Full Text] [Related]

  • 11. Basophil activation test: do not lose control.
    Maietta G.
    Eur Ann Allergy Clin Immunol; 2015 Mar 10; 47(2):36-7. PubMed ID: 25781191
    [No Abstract] [Full Text] [Related]

  • 12. Immunological intervention with anti-immunoglobulin-E antibody to prevent asthma exacerbations.
    Chanez P.
    Eur Respir J; 2001 Aug 10; 18(2):249-50. PubMed ID: 11529279
    [No Abstract] [Full Text] [Related]

  • 13. [Dermatological implications of omalizumab, an anti-IgE antibody].
    Di Lucca-Chrisment J.
    Rev Med Suisse; 2015 Apr 01; 11(468):779-80, 782-3. PubMed ID: 26021140
    [Abstract] [Full Text] [Related]

  • 14. Anti-IgE and chemotherapy: a critical appraisal of treatment options for severe asthma.
    Walters EH, Walters JA, Wood-Baker R.
    Expert Opin Pharmacother; 2007 Apr 01; 8(5):585-92. PubMed ID: 17376014
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Omalizumab for asthma: indications, off-label uses and future directions.
    Ben-Shoshan M.
    Recent Pat Inflamm Allergy Drug Discov; 2010 Nov 01; 4(3):183-92. PubMed ID: 20807194
    [Abstract] [Full Text] [Related]

  • 20. Aspirin tolerance following omalizumab therapy in a patient with aspirin-exacerbated respiratory disease.
    Aksu K, Kurt E.
    Allergol Immunopathol (Madr); 2013 Nov 01; 41(3):208-10. PubMed ID: 22763305
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.